EXS has had years of good drill results etc, and the market rarely appreciated any of them for more then a day or two.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025